AbbVie, Inc. (ABBV)
274.28
-6.84
(-2.43%)
USD |
NYSE |
Oct 13, 16:00
274.98
+0.70
(+0.26%)
After-Hours: 20:00
AbbVie Market Cap : 484.67B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 496.76B |
| October 09, 2026 | 488.54B |
| October 08, 2026 | 481.39B |
| October 07, 2026 | 479.51B |
| October 06, 2026 | 471.26B |
| October 05, 2026 | 469.62B |
| October 02, 2026 | 464.42B |
| October 01, 2026 | 459.31B |
| September 30, 2026 | 462.25B |
| September 29, 2026 | 465.25B |
| September 28, 2026 | 470.54B |
| September 25, 2026 | 467.11B |
| September 24, 2026 | 468.49B |
| September 23, 2026 | 468.41B |
| September 22, 2026 | 468.64B |
| September 21, 2026 | 467.35B |
| September 18, 2026 | 466.44B |
| September 17, 2026 | 466.54B |
| September 16, 2026 | 463.87B |
| September 15, 2026 | 464.81B |
| September 14, 2026 | 462.57B |
| September 11, 2026 | 454.35B |
| September 10, 2026 | 450.60B |
| September 09, 2026 | 443.38B |
| September 08, 2026 | 439.61B |
| Date | Value |
|---|---|
| September 04, 2026 | 453.18B |
| September 03, 2026 | 459.81B |
| September 02, 2026 | 462.48B |
| September 01, 2026 | 459.42B |
| August 31, 2026 | 453.11B |
| August 28, 2026 | 451.45B |
| August 27, 2026 | 456.17B |
| August 26, 2026 | 464.56B |
| August 25, 2026 | 469.67B |
| August 24, 2026 | 467.43B |
| August 21, 2026 | 468.20B |
| August 20, 2026 | 462.67B |
| August 19, 2026 | 469.99B |
| August 18, 2026 | 457.53B |
| August 17, 2026 | 442.35B |
| August 14, 2026 | 440.81B |
| August 13, 2026 | 443.22B |
| August 12, 2026 | 439.58B |
| August 11, 2026 | 441.93B |
| August 10, 2026 | 438.18B |
| August 07, 2026 | 434.77B |
| August 06, 2026 | 430.94B |
| August 05, 2026 | 435.05B |
| August 04, 2026 | 430.81B |
| August 03, 2026 | 433.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 33.82B |
| Gilead Sciences, Inc. | 183.52B |
| Amgen, Inc. | 223.15B |
| REGENXBIO, Inc. | 392.69M |
| Abbott Laboratories | 177.64B |
Market Cap Related Metrics
| PE Ratio | 77.55 |
| PS Ratio | 7.552 |
| PEG Ratio | 1.135 |
| Price to Free Cash Flow | 26.70 |
| Price | 274.28 |
| Earnings Yield | 1.29% |
| PEGY Ratio | 1.096 |
| Operating PE Ratio | 22.09 |
| Normalized PE Ratio | 34.06 |